Zhichao Duan, Ph.D. - Related publications

2009 Mechanical Engineering University of Southern California, Los Angeles, CA, United States 
Mechanical Engineering
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
15 most relevant papers in past 60 days:
Year Citation  Score
2019 Kars MD, Yıldırım G. Determination of the target proteins in chemotherapy resistant breast cancer stem cell-like cells by protein array. European Journal of Pharmacology. 848: 23-29. PMID 30707960 DOI: 10.1016/j.ejphar.2019.01.052   
2019 Beauvarlet J, Mergny JL, Djavaheri-Mergny M. Activation of the Ataxia Telangiectasia Mutated/Autophagy pathway by a G-quadruplex ligand links senescence with apoptosis. Molecular & Cellular Oncology. 6: 1604047. PMID 31211231 DOI: 10.1080/23723556.2019.1604047   
2019 Fürst K, Steder M, Logotheti S, Angerilli A, Spitschak A, Marquardt S, Schumacher T, Engelmann D, Herchenröder O, Rupp RAW, Pützer BM. DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression. Cancer Letters. 442: 299-309. PMID 30445206 DOI: 10.1016/j.canlet.2018.11.009   
2019 Andrade Meirelles M, B Braga C, Ornelas C, Pilli RA. Synthesis of Nitrogen-Containing Goniothalamin Analogues with Higher Cytotoxic Activity and Selectivity Against Cancer Cells. Chemmedchem. PMID 31260170 DOI: 10.1002/cmdc.201900281   
2019 Dib C, Zakharova V, Popova E, Kiseleva E, Chernyak B, Lipinski M, Vassetzky YS. DUX4 Pathological Expression: Causes and Consequences in Cancer. Trends in Cancer. 5: 268-271. PMID 31174839 DOI: 10.1016/j.trecan.2019.03.001   
2019 Dacosta-Noble P, Costantini A, Dumenil C, Dumoulin J, Helly de Tauriers P, Giraud V, Labrune S, Emile JF, Alvarez JC, Chinet T, Giroux Leprieur E. Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients. Plos One. 14: e0219080. PMID 31260495 DOI: 10.1371/journal.pone.0219080   
2019 Laikova KV, Oberemok VV, Krasnodubets AM, Gal'chinsky NV, Useinov RZ, Novikov IA, Temirova ZZ, Gorlov MV, Shved NA, Kumeiko VV, Makalish TP, Bessalova EY, Fomochkina II, Esin AS, Volkov ME, et al. Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs. Molecules (Basel, Switzerland). 24. PMID 30999681 DOI: 10.3390/molecules24081516   
2019 Nestor MS, Berman B, Goldberg D, Cognetta AB, Gold M, Roth W, Cockerell CJ, Glick B. Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids. The Journal of Clinical and Aesthetic Dermatology. 12: 12-18. PMID 30881578   
2019 Sammons S, Kornblum NS, Blackwell KL. Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer. Targeted Oncology. 14: 1-12. PMID 30136059 DOI: 10.1007/s11523-018-0587-9   
2019 Stegmann S, Werner JM, Kuhl S, Röhn G, Krischek B, Stavrinou P, Goldbrunner R, Timmer M. Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas. Anticancer Research. 39: 2299-2306. PMID 31092421 DOI: 10.21873/anticanres.13346   
2019 Rajabi S, Dehghan MH, Dastmalchi R, Jalali Mashayekhi F, Salami S, Hedayati M. The roles and role-players in thyroid cancer angiogenesis. Endocrine Journal. 66: 277-293. PMID 30842365 DOI: 10.1507/endocrj.EJ18-0537   
2019 Clift R, Souratha J, Garrovillo SA, Zimmerman S, Blouw B. Remodeling the Tumor Microenvironment Sensitizes Breast Tumors to Anti- Programmed Death-Ligand 1 Immunotherapy. Cancer Research. PMID 31248966 DOI: 10.1158/0008-5472.CAN-18-3060   
2019 Zaraei SO, Abduelkarem AR, Anbar HS, Kobeissi S, Mohammad M, Ossama A, El-Gamal MI. Sulfamates in drug design and discovery: Pre-clinical and clinical investigations. European Journal of Medicinal Chemistry. 179: 257-271. PMID 31255926 DOI: 10.1016/j.ejmech.2019.06.052   
2019 Tanaka A, Sakaguchi S. Targeting Treg cells in cancer immunotherapy. European Journal of Immunology. PMID 31257581 DOI: 10.1002/eji.201847659   
2019 Werner JM, Kuhl S, Ulrich K, Krischek B, Stavrinou P, Goldbrunner R, Timmer M. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas. World Neurosurgery. PMID 31125770 DOI: 10.1016/j.wneu.2019.05.112